Timothy O'Brien

MetroHealth Medical CenterCleveland, Ohio - 44109 (216-778-2223) |
- CLINICAL TRIALS 3
- CONDITIONS6
- INTERVENTIONS15
- SINCE2005

Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors
November 2005 - December 2012

Erlotinib Docetaxel and Radiation Therapy in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
November 2007 - December 2009

Gemcitabine Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
December 2006 - December 2009
Neoplasms
Pancreatic Neoplasms
Head and Neck Neoplasms
Neurotoxicity Syndromes
Carcinoma, Squamous Cell
Neoplasms, Squamous Cell
Intensity-Modulated Radiation Therapy
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Immunoenzyme Technique
Pharmacological Study
Bevacizumab
Docetaxel
Therapeutic Conventional Surgery
Erlotinib Hydrochloride
Radiation Therapy
Polymerase Chain Reaction
Gemcitabine
Management Of Therapy Complications
Fluorescence In Situ Hybridization
Infusional 5-Fluorouracil



